Patents by Inventor Hiroshi Nagase

Hiroshi Nagase has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230382162
    Abstract: An outer surface of a tire can include a tread surface and a pair of side surfaces. A contour line of the tread surface can include a center arc, a pair of middle arcs, a pair of side arcs, and a pair of shoulder arcs. A contour line of each side surface can be connected to the shoulder arc. A position, on the outer surface, corresponding to a ground-contact end obtained by applying a load that is 80% of a standardized load, to the tire in a standardized state, and bringing the tire into contact with a flat surface is a reference ground-contact position, and a boundary between the shoulder arc and the side arc is a reference boundary. The reference boundary can be located axially outward of the reference ground-contact position. A ratio of a distance in an axial direction from an equator plane to the reference boundary to a distance in the axial direction from the equator plane to a tread reference end TE can be not less than 0.94 and not greater than 0.98.
    Type: Application
    Filed: May 23, 2023
    Publication date: November 30, 2023
    Applicant: Sumitomo Rubber Industries, Ltd.
    Inventors: Hiroshi KIKUCHI, Masahiro NAGASE, Shouta MAKINO
  • Publication number: 20230375781
    Abstract: An electro-optic device which is provided with: a substrate, an optical waveguide formed on the substrate, and an upper electrode formed on the optical waveguide. The electro-optic device is further provided with a buffer layer formed between the substrate and the upper electrode, and a boundary portion of the optical waveguide and the buffer layer forms an oxide layer different from the optical waveguide and the buffer layer in composition.
    Type: Application
    Filed: September 29, 2021
    Publication date: November 23, 2023
    Applicant: TDK CORPORATION
    Inventors: Hiroshi TAKE, Kenji NAGASE, Anthony Reymund Melad BINARAO, Cheng Bu HENG
  • Publication number: 20230333417
    Abstract: An optical modulator, including: a substrate; a plurality of electro-optic material layers formed on the substrate; and an electrode formed on the electro-optic material layer; wherein the electro-optic material layer has a patterned RF portion waveguide that applies a modulated signal and a patterned DC portion waveguide that applies a direct current bias signal; and on a section perpendicular to a light propagation direction, the sectional area of the DC portion waveguide is greater than the sectional area of the RF portion waveguide.
    Type: Application
    Filed: September 29, 2021
    Publication date: October 19, 2023
    Applicant: TDK CORPORATION
    Inventors: Kenji NAGASE, Hiroshi TAKE, Anthony Reymund Melad BINARAO, Cheng Bu HENG
  • Publication number: 20230314710
    Abstract: The present invention provides an optical device and an optical modulator, the optical device comprises an optical waveguide, at an surface of plate-like or film-like electro-optic material forming the optical waveguide, 3 locations are selected in the extension direction of the optical waveguide, and 2 locations are selected in the width direction of the optical waveguide in a range of a region of 0.1×0.1 ?m, and for a total of 6 locations, an surface roughness RMS is measured with Atomic Force Microscope, and an average of the RMS is 5.1 nm or less. According to the optical device in the present invention, the occurrence of micro-cracks at the optical waveguide can be suppressed, thereby reducing the light propagation loss.
    Type: Application
    Filed: March 28, 2023
    Publication date: October 5, 2023
    Applicant: TDK CORPORATION
    Inventors: Kenji NAGASE, Hiroshi TAKE, Anthony Reymund Melad BINARAO, Cheng Bu HENG
  • Publication number: 20230314852
    Abstract: An optical device, including a substrate; an optical waveguide provided in a predetermined region of the substrate and formed of an electro-optic material film; a protective layer formed adjacent to the optical waveguide; and a non-light-propagation optical waveguide provided outside the predetermined region, wherein the surface roughness of the non-light-propagation optical waveguide is RMS 0.5 nm or more. According to the optical device, the occurrence of micro-cracks on the optical waveguide can be suppressed, thereby reducing the light propagation loss.
    Type: Application
    Filed: March 27, 2023
    Publication date: October 5, 2023
    Applicant: TDK CORPORATION
    Inventors: Kenji NAGASE, Hiroshi TAKE, Anthony Reymund Melad BINARAO, Cheng Bu HENG
  • Publication number: 20230299337
    Abstract: An all-solid-state battery comprises a power generation element and a restraint member. The restraint member applies a pressure of 0.5 MPa or less to the power generation element. The power generation element includes a positive electrode layer, a solid electrolyte layer, and a negative electrode layer. The solid electrolyte layer is interposed between the positive electrode layer and the negative electrode layer. The positive electrode layer includes a composite particle. The composite particle includes a positive electrode active material particle and a covering layer. The covering layer covers at least part of a surface of the positive electrode active material particle. The covering layer includes a sulfide solid electrolyte.
    Type: Application
    Filed: March 7, 2023
    Publication date: September 21, 2023
    Applicants: TOYOTA JIDOSHA KABUSHIKI KAISHA, Panasonic Holdings Corporation
    Inventors: Hiroshi NAGASE, Yusuke ITO, Hiroki YABE, Izuru SASAKI
  • Publication number: 20230296929
    Abstract: An optical modulation element is provided with a substrate, a waveguide layer formed on the substrate, a dielectric layer formed on the waveguide layer, and an electrode formed on the dielectric layer. An outer peripheral end portion of the dielectric layer has an offset area positioned inside an outer peripheral end portion of the substrate. In at least a part of the offset area, a distance from the outer peripheral end portion of the substrate to the outer peripheral end portion of the dielectric layer is equal to or less than a distance from the outer peripheral end portion of the substrate to the outer peripheral end portion of the electrode.
    Type: Application
    Filed: February 6, 2023
    Publication date: September 21, 2023
    Inventors: Hiroki HARA, Takashi KIKUKAWA, Hiroshi TAKE, Kenji NAGASE, Shuntaro KODAMA
  • Patent number: 11737735
    Abstract: A physiological information system includes a patient monitor configured to acquire a vital sign based on a vital sign signal of a subject, and an ultrasonic measuring apparatus configured to acquire ultrasonic images based on ultrasonic waves transmitted toward the subject and received from the subject. The patient monitor includes a storage device configured to store measured data of the vital signs in association with measurement dates and times, and to store the ultrasonic images in association with image capture timings, and a controller configured to display a screen on a display section based on data, including the measured data and the ultrasonic images, stored in the storage device.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: August 29, 2023
    Assignee: NIHON KOHDEN CORPORATION
    Inventors: Mitsuhiro Oura, Sou Kumagai, Wataru Matsuzawa, Nobuyuki Yasumaru, Kazuya Nagase, Hiroshi Torigai, Naoki Fukushima
  • Patent number: 11673867
    Abstract: The present invention aims to provide a novel low-molecular-weight compound showing an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I): wherein each symbol is as described in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: June 13, 2023
    Assignees: University of Tsukuba, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Hiroshi Nagase, Tsuyoshi Saitoh, Masashi Yanagisawa, Yoko Irukayama
  • Publication number: 20230159530
    Abstract: A morphinan derivative represented by the following general formula (I): wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms, etc.; R2 represents heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S and at least one carbon atom as ring-constituting atoms, containing at least one set of adjacent ring-constituting atoms bound by a double bond, and further substituted with at least one oxo group; Y binds to a carbon atom as a ring-constituting atom of R2; R3, R4, and R5 represent hydrogen, hydroxy, etc.; R6a and R6b represent hydrogen, etc.; R7 and R8 represent hydrogen, etc.; R9 and R10, which are the same or different, represent hydrogen, etc.; X represents O or CH2; and Y represents C(?O)); a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an anxiolytic drug, antidepressant, etc.
    Type: Application
    Filed: January 9, 2023
    Publication date: May 25, 2023
    Applicant: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi NAGASE, Hideaki FUJII, Akiyoshi SAITOH, Eriko NAKATA, Masaaki HIROSE, Isao OOI, Kohei HAYASHIDA
  • Patent number: 11643411
    Abstract: A morphinan derivative represented by the following general formula (I): wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms, etc.; R2 represents heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S and at least one carbon atom as ring-constituting atoms, containing at least one set of adjacent ring-constituting atoms bound by a double bond, and further substituted with at least one oxo group; Y binds to a carbon atom as a ring-constituting atom of R2; R3, R4, and R5 represent hydrogen, hydroxy, etc.; R6a and R6b represent hydrogen, etc.; R7 and R8 represent hydrogen, etc.; R9 and R10, which are the same or different, represent hydrogen, etc.; X represents O or CH2; and Y represents C(?O)); a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an anxiolytic drug, antidepressant, etc.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: May 9, 2023
    Assignee: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi Nagase, Hideaki Fujii, Akiyoshi Saitoh, Eriko Nakata, Masaaki Hirose, Isao Ooi, Kohei Hayashida
  • Publication number: 20230132191
    Abstract: A method for therapeutic treatment of pain-associated anxiety or depression in a mammalian subject in need thereof, that includes administering to the subject an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits an opioid ? receptor agonist activity.
    Type: Application
    Filed: December 15, 2022
    Publication date: April 27, 2023
    Applicant: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi NAGASE, Hideaki FUJII, Akiyoshi SAITOH, Eriko NAKATA, Masaaki HIROSE, Isao OOI, Kohei HAYASHIDA
  • Patent number: 11633392
    Abstract: The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid ? receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid ? receptor-related diseases (for example, headache) can be treated or prevented.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: April 25, 2023
    Assignee: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi Nagase, Hideaki Fujii, Akiyoshi Saitoh, Eriko Nakata, Masaaki Hirose, Isao Ooi, Kohei Hayashida
  • Publication number: 20220246912
    Abstract: A main object of the present disclosure is to provide an all solid state battery with low resistance. The present disclosure achieves the object by providing an all solid state battery comprising a cathode active material layer, an anode active material layer, and a solid electrolyte layer arranged between the cathode active material layer and the anode active material layer; wherein the anode active material layer includes: a first anode active material and a second anode active material; the first anode active material is a lithium titanate; in the second anode active material, when a discharge capacity at a potential of 1.0 V vs Li+/Li or more and 2.0 V vs Li+/Li or less signifies 100% discharge capacity, and when P1 designates an average potential in a capacity of 0% or more and 50% or less of the 100% discharge capacity, and P2 designates an average potential in a capacity of 50% or more and 100% or less of the 100% discharge capacity, a difference between the P2 and the P1 is 0.
    Type: Application
    Filed: January 12, 2022
    Publication date: August 4, 2022
    Inventor: Hiroshi NAGASE
  • Publication number: 20220246913
    Abstract: A main object of the present disclosure is to provide an anode active material layer with low resistance. The present disclosure achieves the object by providing an anode active material layer to be used in an all solid state battery, the anode active material layer comprises: a first anode active material and a second anode active material; wherein the first anode active material is a lithium titanate; in the second anode active material, when a discharge capacity at a potential of 1.0 V vs Li+/Li or more and 2.0 V vs Li+/Li or less signifies 100% discharge capacity, and when P1 designates an average potential in a capacity of 0% or more and 50% or less of the 100% discharge capacity, and P2 designates an average potential in a capacity of 50% or more and 100% or less of the 100% discharge capacity, a difference between the P2 and the P1 is 0.
    Type: Application
    Filed: January 18, 2022
    Publication date: August 4, 2022
    Inventor: Hiroshi NAGASE
  • Publication number: 20210371422
    Abstract: A compound represented by the following general formula (I), wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms and the alkylene moiety has 1 to 5 carbon atoms, or the like, R2 represents a 4- to 7-membered saturated heterocycle containing one or two heteroatoms which may be the same or different and are selected from N, O, and S, and two or more carbon atoms as ring-constituting atoms, the heterocycle may be substituted with a substituent such as an oxo group, R2 binds to Y via a carbon atom as a ring-constituting atom of R2, R3, R4, and R5, which are the same or different, represent hydrogen; hydroxy; or the like, R6a and R6b, which are the same or different, represent hydrogen or the like, R7 and R8, which are the same or different, represent hydrogen or the like, R9 and R10, which are the same or different, represent hydrogen or the like, X represents O or CH2, and Y represents C(?O) or the like), a tautomer of the compound, a stereoisome
    Type: Application
    Filed: August 8, 2017
    Publication date: December 2, 2021
    Applicant: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi NAGASE, Hideaki FUJII, Akiyoshi SAITOH, Eriko NAKATA, Masaaki HIROSE, Isao OOI, Kohei HAYASHIDA
  • Patent number: 11011745
    Abstract: To provide an anode mixture configured to, when used in an all-solid-state battery, decrease the resistance of the all-solid-state battery and increase the charging performance of the all-solid-state battery, wherein the anode mixture is an anode mixture for an all-solid-state battery comprising an anode comprising an anode mixture layer; wherein the anode mixture contains a first anode active material and a second anode active material; and wherein a difference between a reaction potential of the first anode active material with respect to lithium metal and a reaction potential of the second anode active material with respect to lithium metal, is 1.0 V or more.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: May 18, 2021
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventor: Hiroshi Nagase
  • Patent number: 10995092
    Abstract: A morphinan derivative represented by the following general formula (I): wherein R1 represents hydrogen, C1-10 alkyl, cycloalkylalkyl where the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms, etc.; R2 represents heterocyclic ring containing 1 to 4 heteroatoms selected from N, O and S and at least one carbon atom as ring-constituting atoms, containing at least one set of adjacent ring-constituting atoms bound by a double bond, and further substituted with at least one oxo group; Y binds to a carbon atom as a ring-constituting atom of R2; R3, R4, and R5 represent hydrogen, hydroxy, etc.; R6a and R6b represent hydrogen, etc.; R7 and R8 represent hydrogen, etc.; R9 and Rio, which are the same or different, represent hydrogen, etc.; X represents O or CH2; and Y represents C(?O)); a tautomer or stereoisomer of the compound, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an anxiolytic drug, antidepressant, etc.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: May 4, 2021
    Assignee: NIPPON CHEMIPHAR CO., LTD.
    Inventors: Hiroshi Nagase, Eriko Nakata, Masaaki Hirose, Isao Ooi
  • Publication number: 20210078955
    Abstract: The present invention aims to provide a novel low-molecular-weight compound showing an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I): wherein each symbol is as described in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.
    Type: Application
    Filed: December 11, 2018
    Publication date: March 18, 2021
    Applicants: University of Tsukuba, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Hiroshi NAGASE, Tsuyoshi SAITOH, Masashi YANAGISAWA, Yoko IRUKAYAMA
  • Patent number: D1001655
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: October 17, 2023
    Assignee: TLV CO., LTD.
    Inventors: Mamoru Nagase, Akira Oizumi, Masashi Matsumoto, Eiji Takenaka, Hiroshi Shiromoto